At the news
? NEUTRALIMPACT 1/10 144 filed Nov 2, 2026 at 15:32 ET
Vanina de Verneuil, an officer of Vir Biotechnology, filed a Form 144 notice of intent to sell 1,343 shares of common stock, with an approximate market value of $15,222. The sale is described as a 'sell-to-cover' transaction to satisfy tax withholding obligations arising from the settlement of a vested equity award. The filing is routine and immaterial relative to the company's $2.0B market cap.
- Filer: Vanina de Verneuil, an officer of Vir Biotechnology
- Proposed sale of 1,343 shares of common stock
- Approximate value: $15,221.96
- Sale is a sell-to-cover for tax obligations on a vested equity award
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access